PRESS RELEASE published on 07/17/2024 at 18:15, 1 year 10 months ago Solid first half 2023/24 results and healthy outlook with continued growth in Q3 2023/24 Omer-Decugis & Cie reports strong first-half revenue growth of 18.3% with a 3.5% EBITDA margin. Positive outlook supported by 15.3% revenue growth in Q3 2023/24, aligning with 2025 targets Financial Results Revenue Growth EBITDA Margin Omer-Decugis & Cie 2025 Targets
BRIEF published on 05/13/2024 at 18:05, 2 years ago Omer-Decugis & Cie posts solid growth in the first half of 2023/24 Acquisitions Financial Growth Omer-Decugis & Cie Fruits And Vegetables Exotic Market
PRESS RELEASE published on 05/13/2024 at 18:00, 2 years ago Omer-Decugis and Cie posts an excellent first half 2023/24 with revenue up sharply by 18.5% to EUR 123.8 million Omer-Decugis & Cie reports strong revenue growth in H1 2023/24, up 18.5% to €123.8 million, driven by strategic acquisitions and product development across divisions Revenue Growth Acquisitions Product Development Omer-Decugis & Cie H1 2023/24
BRIEF published on 05/07/2024 at 14:05, 2 years ago Resumption of imports of mangoes from West Africa to the port of Dunkirk SIIM Omer-Decugis & Cie Mangoes Dunkirk Import
Published on 05/20/2026 at 00:00, 18 minutes ago Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program
Published on 05/19/2026 at 19:45, 4 hours 33 minutes ago Karbon-X and Evertrak Sign Letter of Intent to Advance Infrastructure-Linked Plastic Waste Reduction Credit Initiative
Published on 05/19/2026 at 16:47, 7 hours 31 minutes ago Lithium South Re-Schedules Plan of Arrangement Closing as a Result of Cease Trade Order
Published on 05/19/2026 at 15:15, 9 hours 3 minutes ago Loop Industries Secures Gujarat Government Alignment Supporting First Commercial Deployment and Multi-Phase India Expansion
Published on 05/19/2026 at 15:00, 9 hours 18 minutes ago Jaguar Health Announces Active Treatment Only Continuation of Pivotal Multicenter Clinical Trial in Pediatric Patients with Microvillus Inclusion Disease (MVID) to Support a New Drug Application (NDA) for Liquid Oral Crofelemer
Published on 05/19/2026 at 21:24, 2 hours 53 minutes ago EQS-Adhoc: ams OSRAM announces the successful pricing of EUR 1 billion 7.250% Senior Notes due 2032, supporting the path to positive Free Cash Flow from 2027 onwards
Published on 05/19/2026 at 19:50, 4 hours 28 minutes ago EQS-Adhoc: fox e-mobility AG: 3 convertible bonds issued
Published on 05/19/2026 at 19:40, 4 hours 37 minutes ago PRC-Saltillo Named to Forbes Accessibility 200 List
Published on 05/19/2026 at 19:05, 5 hours 12 minutes ago Casper Ruud Returns to Stockholm as Bybit EU Expands Across the Nordics
Published on 05/19/2026 at 18:56, 5 hours 21 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/19/2026 at 18:34, 5 hours 43 minutes ago Availability of preparatory documents for the annual general meeting to be held on June 9, 2026
Published on 05/19/2026 at 17:45, 6 hours 33 minutes ago EURAZEO INVESTS IN NEXTRON SYSTEMS, A GERMAN CYBERSECURITY COMPANY SPECIALISED IN THREAT INTELLIGENCE AND CYBER FORENSICS
Published on 05/18/2026 at 22:25, 1 day 1 hour ago Results of the public buy-out offer and implementation of the subsequent squeeze-out of TERACT shares
Published on 05/18/2026 at 18:00, 1 day 6 hours ago Covivio Hotels - Covivio continues its expansion in hospitality in Southern Europe with a new acquisition in Torremolinos, Spain
